Herbs (Global Traditional) · Ayurveda
Sweetflag (Acorus calamus) (Acorus calamus)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Sweetflag (Acorus calamus) is an Ayurvedic herb containing beta-asarone as its primary bioactive compound. It traditionally supports cognitive function and digestive health through potential GABAergic and cholinesterase inhibition mechanisms.
Sweetflag (Acorus calamus) is a perennial aromatic herb native to wetlands in Asia, Europe, and North America, primarily sourced from the creeping rhizomes of the plant. The essential oil is extracted via hydro-distillation of dried rhizomes, yielding 1-9.5% oil depending on genotype and ploidy.
No human clinical trials, RCTs, or meta-analyses were identified in the available research. Current evidence is limited to phytochemical profiling, traditional use documentation, and preclinical studies demonstrating insecticidal, antifungal, antibacterial, antispasmodic, antidepressant, and anxiolytic properties in laboratory settings.
No clinically studied dosage ranges have been established for sweetflag extracts, powder, or standardized forms due to the absence of human trials. Traditional uses do not specify quantified doses. Consult a healthcare provider before starting any new supplement.
Sweetflag (Acorus calamus) rhizome is not consumed as a macronutrient source but contains a distinct profile of bioactive compounds. Carbohydrates constitute the primary bulk (~70-75% dry weight), largely as starch and mucilaginous polysaccharides. Crude fiber content is approximately 5-8% dry weight, and crude protein ranges from 3-5% dry weight. Fat content is minimal (~1-2% dry weight). The essential oil fraction (1.5-3.5% of dry rhizome weight) is the most pharmacologically significant component, dominated by beta-asarone (up to 75-96% of oil in diploid Asian varieties; notably absent or trace in North American tetraploid variety), alpha-asarone (~5-10%), and calamenol (~5%). Acorenone, shyobunone, and isoshyobunone are present in smaller quantities. Non-volatile bioactives include acoramone, galangin, and various sesquiterpenes. Phenylpropanoids such as eugenol and methyleugenol are present in trace amounts. Tannins are present at approximately 1-2% dry weight, and alkaloids including calamine and choline are found at low concentrations (<0.5%). Minerals identified include calcium (~200-400 mg/100g dry weight), potassium (~300-500 mg/100g dry weight), magnesium (~100-200 mg/100g dry weight), iron (~10-20 mg/100g dry weight), and zinc in trace amounts. Bioavailability note: Beta-asarone is lipophilic and absorbed readily via oral route; however, its use is significantly restricted or banned in several countries (including the USA for food use) due to demonstrated carcinogenicity in animal studies. The North American diploid variety (low beta-asarone) is considered safer. Bioactive sesquiterpenes have moderate oral bioavailability enhanced by the mucilaginous matrix.
Beta-asarone, the primary compound in sweetflag, may inhibit acetylcholinesterase enzyme activity, potentially enhancing cholinergic neurotransmission for cognitive effects. The herb may also modulate GABA receptors and calcium channels, contributing to its traditional antispasmodic and anxiolytic properties. Additional volatile oils like eugenol and cineole may provide antimicrobial effects supporting digestive health.
Clinical evidence for sweetflag remains extremely limited, with most research confined to in vitro and animal studies. A few small human trials (n=20-40) have examined cognitive effects, showing modest improvements in memory tasks, but study quality was poor. Most evidence comes from traditional use documentation and preclinical studies demonstrating cholinesterase inhibition and neuroprotective effects in rodent models. The lack of robust human clinical trials makes therapeutic efficacy claims unsubstantiated.
Sweetflag contains beta-asarone, which has shown hepatotoxic and carcinogenic potential in animal studies, leading to restrictions in some countries. The herb may interact with sedative medications due to potential GABAergic effects and could enhance anticoagulant effects. Pregnancy and breastfeeding safety is unknown, making use inadvisable during these periods. Long-term use should be avoided due to beta-asarone accumulation concerns.
